Cleared Traditional

EXCELLAGEN (K110318) - FDA 510(k) Clearance

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2011
Decision
243d
Days
-
Risk

K110318 is an FDA 510(k) clearance for the EXCELLAGEN. Classified as Wound Dressing With Animal-derived Material(s) (product code KGN).

Submitted by Tissue Repair Company (San Diego, US). The FDA issued a Cleared decision on October 3, 2011 after a review of 243 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Tissue Repair Company devices

Submission Details

510(k) Number K110318 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 02, 2011
Decision Date October 03, 2011
Days to Decision 243 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
128d slower than avg
Panel avg: 115d · This submission: 243d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code KGN Wound Dressing With Animal-derived Material(s)
Device Class -

Regulatory Peers - KGN Wound Dressing With Animal-derived Material(s)

All 186
Devices cleared under the same product code (KGN) and FDA review panel - the closest regulatory comparables to K110318.
Catalyze
K253204 · BioTissue Holdings, Inc. · Jun 2026
Roosin Collagen Dressing
K253974 · Roosin Medical Co., Ltd. · Jun 2026
Roosin Collagen Powder
K254034 · Roosin Medical Co., Ltd. · Jun 2026
MatriDerm
K261224 · Medskin Solutions Dr. Suwelack AG · May 2026
Derma-Gide
K260532 · Geistlich Pharma AG · Mar 2026
LacertaMatrix
K260218 · Lacerta Life Sciences · Feb 2026